Dr. Inmaculada Yruela graduated and earned her doctorate in Chemistry at the University of Sevilla (Spain). She has been a visiting guest scientist at the Max Planck Institute for Chemical Energy Conversion in Mülheim an der Ruhr (Germany) and at Department of Biochemistry and Molecular Biology in Indiana University School of Medicine (USA). She is research scientist at the CSIC and group leader at Computational and Structural Biology in Estación Experimental de Aula (CSIC), Zaragoza (Spain). From the early 1990s she has been studying the relationship between the structure and function of redox protein complexes involved in photosynthesis (I.e. PSII, cytochromes) among other, and more recently the role of intrinsic ductiliity and plasticity of proteins in organismal complexity, multicellularity and evolution. She has led science outreach projects. She is currently member of SEBBM and editor-in chief of SEBBM Journal.

Atherosclerosis, inflammatory diseases, biomarkers

Dr. Irene Díaz-Moreno is Full Professor of Biochemistry and Molecular Biology at the Institute of Chemical Research of the Scientific Research Centre Isla de la Cartuja – cicCartuja, in Seville (Spain). She was awarded with her Ph.D. with European mention from the University of Seville in 2005. Dr. Irene Díaz-Moreno has worked in collaboration with groups at the Universities of Göteborg (Sweden) and Leiden (The Netherlands) on molecular recognition between metalloproteins involved in electron-transfer processes. She was an EMBO postdoctoral fellow (2006–2008) at the NIMR-MRC in London (UK), working on the regulatory mechanisms of mRNA decay by RNA-binding proteins. In 2010, she got a permanent position at the University of Seville, where she is developing research projects on Biointeractomics field, as well as on the post-translational regulation of biological macromolecules.

EU-OPENSCREEN is a not-for-profit European Research Infrastructure Consortium (ERIC) for chemical biology and early drug discovery. We support all stages of a chemical tool development project, including assay adaptation, high-throughput screening, and chemical optimisation of the ‘hit’ compounds. EU-OPENSCREEN operates an open-access database and a unique, common compound collection. Our main library, the European Chemical Biology Library (ECBL), consists of over 100.000 compounds.

biochemistry, molecular biology, bioinformatics, molecular visualisation, technology for teaching and learning

I am the FEBS Events Associate – Advanced Courses, Congress, 3+ at FEBS, supporting the delivery of those events. Previously I was the Communications and Digital Platforms Associate, also at FEBS, and worked on platforms such as the FEBS Network and FEBS website. Before joining FEBS I managed the grant programmes of a number of UK research charities, mainly in the field of cancer, as well as supported the fundraising at those organisations. I also developed e-learning resources at the Institute of Cancer Research. I have a BSc in Biochemistry and an MSc in Nutrition. After years in London I have now moved back to Spain.

The International Union of Biochemistry and Molecular Biology unites scientists in 75 countries or regions through a society, national council, or academy of sciences.

The FEBS-IUBMB-ENABLE Conference is a joint initiative of FEBS, IUBMB, and several leading European biomedical research institutes (the ENABLE partners), building on a successful project originally funded by the EU Horizon 2020 Research and Innovation Programme (2017–2020). These interdisciplinary, international, three-day events are organized by and for young researchers in the molecular life sciences and attract up to 300 participants from around the world. Each conference features a scientific symposium, a career day, and outreach activities. ENABLE (the European Academy for Biomedical Science) was launched in 2017 through the collaboration of four renowned European institutes: the Institute for Research in Biomedicine (IRB Barcelona, Spain), the Novo Nordisk Foundation Center for Protein Research (NNF-CPR, Denmark), the Radboud Institute for Molecular Life Sciences at Radboudumc (Netherlands), and the European School of Molecular Medicine (SEMM, Italy). These core institutions hosted the first four conferences from 2017 to 2021. In 2022, FEBS and IUBMB joined forces with the ENABLE founders to relaunch the initiative as FEBS-IUBMB-ENABLE, expanding its reach and impact. In this new cycle, institutions can apply to become associated centres and host one of the events.